Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. | Nat Commun | 2023 | 37460545 | PubTator, text mining | PubMed |
| Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features. | Clin Cancer Res | 2023 | 37449970 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing: Opportunities and Challenges for Studies on Corneal Biology in Health and Disease. | Cells | 2023 | 37443842 | PubTator, text mining | PubMed |
| Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin. | Cells | 2023 | 37443817 | PubTator, text mining | PubMed |
| Long noncoding RNAs, glucose metabolism and cancer (Review). | Oncol Lett | 2023 | 37427347 | PubTator, text mining | PubMed |
| Exploration of the shared genes and signaling pathways between lung adenocarcinoma and idiopathic pulmonary fibrosis. | J Thorac Dis | 2023 | 37426132 | PubTator, text mining | PubMed |
| LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer. | Transl Lung Cancer Res | 2023 | 37425423 | PubTator, text mining | PubMed |
| Ocular surface complications following biological therapy for cancer. | Front Toxicol | 2023 | 37424746 | PubTator, text mining | PubMed |
| Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy. | Proc Natl Acad Sci U S A | 2023 | 37399385 | PubTator, text mining | PubMed |
| Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma. | Front Immunol | 2023 | 37398643 | PubTator, text mining | PubMed |
| The role of CXCL family members in different diseases. | Cell Death Discov | 2023 | 37393391 | PubTator, text mining | PubMed |
| Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity. | Front Immunol | 2023 | 37388742 | PubTator, text mining | PubMed |
| Prognostic and immunological potential of PPM1G in lung adenocarcinoma. | Mol Med Rep | 2023 | 37387407 | PubTator, text mining | PubMed |
| Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention. | Front Cell Dev Biol | 2023 | 37384249 | PubTator, text mining | PubMed |
| A tricarboxylic acid cycle-based machine learning model to select effective drug targets for the treatment of esophageal squamous cell carcinoma. | Front Pharmacol | 2023 | 37383713 | PubTator, text mining | PubMed |
| Defining developmental trajectories of prosensory cells in human inner ear organoids at single-cell resolution. | Development | 2023 | 37381908 | PubTator, text mining | PubMed |
| Chemokine Levels among Patients with Middle East Respiratory Syndrome Coronavirus Infection. | Vaccines (Basel) | 2023 | 37376437 | PubTator, text mining | PubMed |
| Epidermal Loss of RORα Enhances Skin Inflammation in a MC903-Induced Mouse Model of Atopic Dermatitis. | Int J Mol Sci | 2023 | 37373387 | PubTator, text mining | PubMed |
| Endothelial Cells and Mitochondria: Two Key Players in Liver Transplantation. | Int J Mol Sci | 2023 | 37373238 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=20